Recent Evidence Regarding Triclosan and Cancer Risk

Author: Dinwiddie Michael T.   Terry Paul D.   Chen Jiangang  

Publisher: MDPI

E-ISSN: 1660-4601|11|2|2209-2217

ISSN: 1660-4601

Source: International Journal of Environmental Research and Public Health, Vol.11, Iss.2, 2014-02, pp. : 2209-2217

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Triclosan is a broad-spectrum antibacterial commonly used in cosmetics, dentifrices, and other consumer products. The compound’s widespread use in consumer products and its detection in breast milk, urine, and serum have raised concerns regarding its potential association with various human health outcomes. Recent evidence suggests that triclosan may play a role in cancer development, perhaps through its estrogenicity or ability to inhibit fatty acid synthesis. Our aims here are to review studies of human exposure levels, to evaluate the results of studies examining the effects of triclosan on cancer development, and to suggest possible directions for future research.

Related content